Electra banks $183m for sHLH drug, and other biofinancings
Electra Therapeutics Secures $183m for sHLH Drug Electra Therapeutics has raised $183 million in a Series C financing round to support its phase 2/3 trial of ELA026, a potential therapy fo…
Electra Therapeutics Secures $183m for sHLH Drug Electra Therapeutics has raised $183 million in a Series C financing round to support its phase 2/3 trial of ELA026, a potential therapy fo…
SSI Social Security Benefits Increase If you are 62 or older and depend on Social Security or Supplemental Security Income (SSI) benefits,…
Marengo Therapeutics to Present at SITC 2025 Marengo Therapeutics, Inc., a clinical-stage biotechnology company, will present a late-break…
Wordle Hints Today: Answer for October 31, 2025 Find today’s Wordle hints and answers to solve the NYT Wordle 1595 for October 31, 2025, a…
Government of Canada Funding Announcement The Honourable Dominic LeBlanc and the Honourable Ginette Petitpas-Taylor will announce funding …
California Prime Recovery Expands Virtual Treatment Programs California Prime Recovery, a Joint Commission-accredited and DHCS-certified b…
Changing Faces: Board Appointments for August and September 2025 Welcome back to Changing Faces, our final round-up for August and Septemb…
The Village Halloween Parade: A Celebration of Identity The Village Halloween Parade, held on October 31, attracts over 2 million people t…